PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29216630-11	2017	However, autophagy promotion by rapamycin increased oil droplet accumulation and LPL and PPARgamma expression.	Sirolimus	32-41	lipoprotein lipase	Homo sapiens	81-84	
18448283-0	2008	Cyclosporine A and Rapamycin induce in vitro cholesteryl ester transfer protein activity, and suppress lipoprotein lipase activity in human plasma.	Sirolimus	19-28	lipoprotein lipase	Homo sapiens	103-121	
18448283-10	2008	CONCLUSIONS: The increase in CETP activity and suppression in LPL activity following CsA and RAPA treatment observed in the present study may be associated with elevated LDL cholesterol levels and hypertriglyceridemia seen in patients administered these drugs.	Sirolimus	93-97	lipoprotein lipase	Homo sapiens	62-65	
18448283-9	2008	LPL activity in post-heparin normal human plasma was suppressed following the co-incubation with CsA, RAPA, FK-506 or MMF whereas HL activity remained unaffected.	Sirolimus	102-106	lipoprotein lipase	Homo sapiens	0-3	
32879215-4	2020	In addition, the effect of E2 on LPL secretion was markedly suppressed by an inhibitor of mammalian target of rapamycin complex (mTORC) 1 and 2, KU0063794, but were not by a mTORC1 inhibitor, rapamycin.	Sirolimus	110-119	lipoprotein lipase	Homo sapiens	33-36	
32879215-4	2020	In addition, the effect of E2 on LPL secretion was markedly suppressed by an inhibitor of mammalian target of rapamycin complex (mTORC) 1 and 2, KU0063794, but were not by a mTORC1 inhibitor, rapamycin.	Sirolimus	192-201	lipoprotein lipase	Homo sapiens	33-36